home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Regulatory Affairs for Biologics

 
  February 01, 2012  
     
 
DIA, Horsham, PA USA
Mar 19 2012 8:30AM - Mar 20 2012 2:30PM


Discuss proven strategies to achieve regulatory compliance for the development of biologics.

 

What you will learn

  • Difference between traditional biologics and biotechnology products
  • Regulatory needs and requirements for biologics
  • Unique aspects in the development of specific biologics such as vaccines and gene therapy
  • Differences in how CBER views product development compared to CDER

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association.  Speakers, agenda and CE information are subject to change without notice.  Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.


Event Code:
12433
 
 
Organized by: DIA
Invited Speakers:
FACULTY
CAROL H. DANIELSON, MS,
DrPH
President
Regulatory Advantage
 
Deadline for Abstracts: Call contact
 
Registration:

For registration questions, please contact Elizabeth Espich  at +1-215-293-5802 or Elizabeth.espich@diahome.org 
For agenda details, please contact Susan Berkelbach at +1-215-442-6183 or Susan.Berkelbach@diahome.org


E-mail: susan.berkelbach@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.